滚动资讯
Lonza NewsIs Lonza Group (SWX:LONN) Pricing Too High After Recent Share Price Swings? - Yahoo FinanceThermo Fisher赛默飞世尔科技公司第四季度财报后股价下跌2.95%，尽管每股收益微超预期且营收同比增长3.9%。FierceBiotech礼来公司放弃与瑞格生物剩余协议，RIPK1抑制剂再遭打击。Thermo FisherThermo Fisher (TMO) Q4 2024 Earnings Transcript - AOL.comWatersWAT (Waters Corporation) rises 1.06 percent after Q4 2025 results, as 7 percent revenue growth offsets minor EPS miss. - Earnings Risk - Cổng thông tin điện tử Tỉnh Sơn LaFierceBiotech麦克森以12.5亿美元将外科部门少数股权置换给阿波罗基金。FierceBiotechAcuityMD raises $80M to help bolster AI in the medtech industryFierceBiotechAACR: NCI leader Letai battles ‘misinformation’ to assure anxious researchers that ‘funding is strong’FierceBiotechMerck goes with Google for AI push, striking enterprise partnership worth up to $1BBioWorldAppointments and advancements for April 22, 2026BioWorldFinancings for April 22, 2026BioWorldIn the clinic for April 22, 2026
FierceBiotech 2026年1月15日

Ocugen公布中期基因疗法数据，规划与Apellis及Astellas竞争路线图

Ocugen公布中期基因疗法数据，规划与Apellis及Astellas竞争路线图

原文
暂时没有全文，请查看原始来源。